Seminars in Radiation Oncology

Papers
(The median citation count of Seminars in Radiation Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy57
Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer35
Effects of Radiation on the Tumor Microenvironment31
Biology of Radiation-Induced Lung Injury30
The Impact of Radiation Therapy on Innate and Adaptive Tumor Immunity30
Evidence-Based Dose Planning Aims and Dose Prescription in Image-Guided Brachytherapy Combined With Radiochemotherapy in Locally Advanced Cervical Cancer28
Type I Interferon Response in Radiation-Induced Anti-Tumor Immunity27
The Radiobiology of Radiopharmaceuticals21
Priming and Propagating Anti-tumor Immunity: Focal Hypofractionated Radiation for in Situ Vaccination and Systemic Targeted Radionuclide Theranostics for Immunomodulation of Tumor Microenvironments20
Automated Radiation Treatment Planning for Cervical Cancer20
Epidemiology of HPV Related Malignancies20
Biology of HPV Mediated Carcinogenesis and Tumor Progression19
The Role of Theranostics in Prostate Cancer18
Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies17
Dosimetry for Optimized, Personalized Radiopharmaceutical Therapy16
Regulatory Aspects of the Use of Artificial Intelligence Medical Software16
Quality Assurance for AI-Based Applications in Radiation Therapy16
Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology15
Diverse Neoantigens and the Development of Cancer Therapies13
Meeting the Global Need for Radiation Therapy in Cervical Cancer—An Overview13
Knowledge-Based Planning for Intact Cervical Cancer12
Novel Radiation Therapy Paradigms and Immunomodulation: Heresies and Hope12
Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations11
Automated Tumor Segmentation in Radiotherapy11
Radiopharmaceutical Chemistry and Drug Development—What's Changed?11
Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer Patients11
Targeting Non-homologous and Alternative End Joining Repair to Enhance Cancer Radiosensitivity10
Radiopharmaceuticals for Neuroendocrine Tumors10
Using Preclinical Data to Design Combination Clinical Trials of Radiation Therapy and Immunotherapy10
Theranostics: The Role of Quantitative Nuclear Medicine Imaging10
Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies10
The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade8
Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC8
Novel Agents and Future Perspectives on Theranostics8
Radiotherapy-Poly(ADP-ribose) Polymerase Inhibitor Combinations: Progress to Date8
Imaging and its Impact on Defining the Oligometastatic State8
Re-Irradiation of Recurrent Non-Small Cell Lung Cancer8
Challenges in Re-Irradiation in the Thorax: Managing Patients with Locally Recurrent Non-Small Cell Lung Cancer7
Artificial Intelligence for Radiation Oncology Applications Using Public Datasets7
Chromosome Missegregation as a Modulator of Radiation Sensitivity7
Intensified Systemic Therapy Regimens in Combination With Definitive Radiation for Treatment of Cervical Cancer7
Uncertainty Assessment for Deep Learning Radiotherapy Applications7
The Spectrum of Metastasis: An Opportunity for Cure?7
Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer6
Aiming for 100% Local Control in Locally Advanced Cervical Cancer: The Role of Complex Brachytherapy Applicators and Intraprocedural Imaging6
Radiopharmaceuticals for Bone Metastases6
The Biological Process of Aging and the Impact of Ionizing Radiation6
The Medical Physics Management of Reirradiation Patients6
Radiation and Modulation of the Tumor Immune Microenvironment in Non–Small Cell Lung Cancer6
Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations6
Balancing Fractionation and Advanced Technology in Consideration of Reirradiation6
Incorporating Magnetic Resonance Imaging (MRI) Based Radiation Therapy Response Prediction into Clinical Practice for Locally Advanced Cervical Cancer Patients6
Artificial Intelligence for Image Registration in Radiation Oncology6
Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC6
DCIS: Risk Assessment in the Molecular Era6
Is It Worth It? Consequences of Definitive Head and Neck Reirradiation5
Immunotherapy for HPV Malignancies5
Hypofractionation in Early Stage Non-Small Cell Lung Cancer5
Challenges in Reirradiation of Intrahepatic Tumors5
Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape5
Tailoring the Omission of Radiotherapy for Early-Stage Breast Cancer Based on Tumor Biology5
Combining Radiation with Immunotherapy: The University of Pennsylvania Experience5
Future Directions in the Use of SAbR for the Treatment of Oligometastatic Cancers5
Mechanisms of Immune Modulation by Radiation5
Regional Nodal Management in the Setting of Up-Front Surgery5
Prevention and Screening of HPV Malignancies5
Advances in Automated Treatment Planning4
Oligometastatic Breast Cancer4
Artificial Intelligence for Outcome Modeling in Radiotherapy4
The Rapid Evolution of Theranostics in Radiation Oncology4
Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology4
Systemic Therapy for Mutation-Driven NSCLC4
Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology4
Potential of Deep Learning in Quantitative Magnetic Resonance Imaging for Personalized Radiotherapy4
Translation of Precision Medicine Research Into Biomarker-Informed Care in Radiation Oncology4
Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence4
Radiation Treatment Deintensification for HPV-Associated Oropharyngeal Cancer3
Treatment De-intensification for HPV-associated Oropharyngeal Cancer: A Definitive Surgery Paradigm3
Ethical Aspects of Artificial Intelligence in Radiation Oncology3
Trials and Tribulations of Radio-Immuno-Oncology3
Emerging Paradigm of Consolidative Thoracic Radiotherapy in Oligometastatic NSCLC3
Integrating Artificial Intelligence and Machine Learning Into Cancer Clinical Trials3
Treatment Intensification in Locally Advanced/Unresectable NSCLC Through Combined Modality Treatment and Precision Dose Escalation3
Multimodality Treatment with Radiotherapy and Immunotherapy in Older Adults: Rationale, Evolving Data, and Current Recommendations3
Emerging Technologies in Mitigating the Risks of Cardiac Toxicity From Breast Radiotherapy3
Seeing is Believing: State of the Art Imaging of Bladder Cancer3
The Promise and Future of Radiomics for Personalized Radiotherapy Dosing and Adaptation3
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer3
The Legacy of RTOG/NRG Protocols in Shaping Current Bladder Preservation Therapy in North America3
Standardization of Artificial Intelligence Development in Radiotherapy3
Radiopharmaceutical Delivery for Theranostics: Pharmacokinetics and Pharmacodynamics3
Recognizing Frailty in Radiation Oncology Clinical Practice: Current Evidence and Future Directions3
To Radiate or Not to Radiate—The Challenges of Pelvic Reirradiation3
Oncometabolites as Regulators of DNA Damage Response and Repair3
Hypoxia-Targeted Dose Painting in Radiotherapy3
0.039339065551758